Journal of Glycobiology
Open Access

N-Linked Glycosylation and its Impact on Immune Response and Inflammation

Carlos Adrian^{* *}Correspondence: Carlos Adrian, Department Applied Biochemistry and Biotechnology, University of Puerto Rico, San Juan, Puerto Rico, Email:

Author info »

Description

N-linked glycosylation, a critical post-translational modification in which carbohydrate chains are covalently attached to proteins, is integral to a vast array of cellular processes. This modification, occurring primarily in the endoplasmic reticulum and Golgi apparatus, is essential for protein folding, stability, and trafficking within the cell. However, its significance extends beyond these basic cellular functions. Increasingly, researchers are uncovering how N-linked glycosylation affects immune response and inflammation, two key aspects of our body's defense mechanisms. The structure and composition of glycans can significantly influence immune cell interactions, signaling pathways, and the regulation of inflammation. Understanding these intricate relationships holds great potential for developing novel therapeutic strategies for a range of immune-related diseases, including autoimmune disorders, cancer, and infections.

Role of glycans in immune cell recognition

Glycans, particularly those attached to glycoproteins through N-linked glycosylation, serve as important markers in immune cell recognition and signaling. The immune system relies on a complex network of receptor-ligand interactions to distinguish between self and non-self, identify pathogens, and coordinate immune responses. Many of these receptors, such as C-type Lectin Receptors (CLRs) and selectins, interact with specific glycan structures to trigger immune signaling pathways. For instance, the interaction of immune receptors with glycoproteins on the surface of pathogens or infected cells can initiate an immune response. The presence or absence of specific sugar moieties can determine whether a cell is recognized as self or foreign. N-linked glycosylation can influence the immunogenicity of a protein or pathogen by altering its glycan profile. These changes may enhance or dampen the immune response, influencing disease outcomes. For example, the glycosylation pattern of the spike protein of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus plays a important role in its ability to bind to the human Angiotensin-Converting Enzyme 2 (ACE2) receptor, facilitating viral entry and infection. Moreover, N-linked glycosylation modulates the activation of immune cells such as dendritic cells, macrophages, and T-cells. These cells express glycan-binding receptors that can recognize pathogen-associated glycan patterns, which in turn influences their activation and subsequent immune responses. Therefore, the ability of pathogens to alter or evade glycan interactions with immune cells is a key factor in their virulence.

Modulating inflammation through glycosylation

Beyond immune cell recognition, N-linked glycosylation plays an important role in modulating inflammation. Inflammatory responses are tightly regulated processes that involve a variety of immune cells and signaling molecules. Glycosylation influences the recruitment and activation of immune cells at sites of inflammation, including neutrophils, macrophages, and lymphocytes. Changes in glycosylation patterns on cell surface glycoproteins can affect cell adhesion, migration, and activation in response to inflammatory signals. One of the well-studied examples of glycosylation's impact on inflammation is the role of selectins in mediating leukocyte trafficking during inflammation. Selectins are cell adhesion molecules that recognize specific carbohydrate structures on the surface of immune cells and endothelial cells. During an inflammatory response, the upregulation of selectins allows immune cells to bind to blood vessel walls, migrate to inflamed tissues, and initiate an immune response. The glycosylation patterns on selectins and their ligands influence the efficiency of this process, with certain glycan modifications either enhancing or inhibiting leukocyte recruitment. Additionally, N-linked glycosylation can influence the function of cytokines, which are critical regulators of the immune response. Many cytokines, such as interleukins and Tumor Necrosis Factor (TNF)-alpha, are glycoproteins whose biological activity can be altered by changes in their glycosylation status. For example, the glycosylation of TNF-alpha affects its ability to bind to its receptors and initiate downstream signaling pathways. Altered glycosylation patterns on cytokines may influence the intensity and duration of the inflammatory response, contributing to chronic inflammation and autoimmune diseases.

Glycosylation and autoimmune diseases

In autoimmune diseases, where the immune system erroneously attacks healthy tissues, N-linked glycosylation plays a pivotal role in modulating the immune response. Changes in the glycosylation patterns of self-proteins or immune cells may lead to an improper immune response. For example, in rheumatoid arthritis, the glycosylation of Immunoglobulin G (IgG), an antibody involved in immune responses, can influence its ability to activate immune cells and cause tissue damage. Aberrant glycosylation of IgG can also lead to the formation of immune complexes that drive inflammation in the joints, exacerbating the disease. Similarly, in diseases like Systemic Lupus Erythematosus (SLE) and multiple sclerosis, altered glycosylation of immune cells and cytokines can contribute to inappropriate immune activation and inflammation. Understanding how these glycosylation changes occur could provide new targets for therapies aimed at modulating immune responses in autoimmune conditions.

Conclusion

In conclusion, N-linked glycosylation is a vital player in the regulation of immune responses and inflammation. By influencing immune cell recognition, cytokine function, and leukocyte trafficking, N-linked glycans serve as key modulators of both protective and pathological immune responses. As our understanding of glycosylation continues to deepen, the potential to employ this modification for therapeutic purposes grows. Whether in enhancing immune responses against infections or cancer, or in moderating harmful inflammation in autoimmune diseases, targeting N-linked glycosylation represents a potential frontier in medical research. With continued progress, the manipulation of glycosylation could prepare for more effective, precise, and personalized treatments for a range of immune-related diseases.